These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 28951197)
1. Clinical presentation of Legionella pneumonia: Evaluation of clinical scoring systems and therapeutic efficacy. Miyashita N; Higa F; Aoki Y; Kikuchi T; Seki M; Tateda K; Maki N; Uchino K; Ogasawara K; Kiyota H; Watanabe A J Infect Chemother; 2017 Nov; 23(11):727-732. PubMed ID: 28951197 [TBL] [Abstract][Full Text] [Related]
2. [Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia]. Roger PM; Risso K; Hyvernat H; Landraud L; Vassallo M; Dellamonica J; de Salvador F; Cua E; Bernardin G Med Mal Infect; 2010 Jun; 40(6):347-51. PubMed ID: 20172672 [TBL] [Abstract][Full Text] [Related]
3. Community-acquired pneumonia. Kirby BD Emerg Med Clin North Am; 1985 Feb; 3(1):179-89. PubMed ID: 4054058 [TBL] [Abstract][Full Text] [Related]
4. A Novel Diagnostic Scoring System to Differentiate between Legionella pneumophila Pneumonia and Streptococcus pneumoniae Pneumonia. Saraya T; Nunokawa H; Ohkuma K; Watanabe T; Sada M; Inoue M; Honda K; Oda M; Ogawa Y; Tamura M; Yokoyama T; Kurai D; Kimura H; Ishii H; Goto H; Takizawa H Intern Med; 2018 Sep; 57(17):2479-2487. PubMed ID: 29607950 [TBL] [Abstract][Full Text] [Related]
5. The atypical pneumonias: clinical diagnosis and importance. Cunha BA Clin Microbiol Infect; 2006 May; 12 Suppl 3():12-24. PubMed ID: 16669925 [TBL] [Abstract][Full Text] [Related]
7. The role of atypical pathogens in community-acquired pneumonia. Gupta SK; Sarosi GA Med Clin North Am; 2001 Nov; 85(6):1349-65, vii. PubMed ID: 11680106 [TBL] [Abstract][Full Text] [Related]
8. Macrolides versus quinolones in Legionella pneumonia: results from the Community-Acquired Pneumonia Organization international study. Griffin AT; Peyrani P; Wiemken T; Arnold F Int J Tuberc Lung Dis; 2010 Apr; 14(4):495-9. PubMed ID: 20202309 [TBL] [Abstract][Full Text] [Related]
9. [Clinical picture of Legionnaires' disease (author's transl)]. Lode H; Schäfer H; Schoeller R; Ruckdeschel R Infection; 1982; 10 Suppl 2():S70-3. PubMed ID: 7107021 [TBL] [Abstract][Full Text] [Related]
10. Clinical diagnosis of Legionella pneumonia revisited: evaluation of the Community-Based Pneumonia Incidence Study Group scoring system. Fernández-Sabé N; Rosón B; Carratalà J; Dorca J; Manresa F; Gudiol F Clin Infect Dis; 2003 Aug; 37(4):483-9. PubMed ID: 12905131 [TBL] [Abstract][Full Text] [Related]
11. Legionella pneumonia due to non-Legionella pneumophila serogroup 1: usefulness of the six-point scoring system. Ito A; Ishida T; Washio Y; Yamazaki A; Tachibana H BMC Pulm Med; 2017 Dec; 17(1):211. PubMed ID: 29246145 [TBL] [Abstract][Full Text] [Related]
12. Severe Legionella pneumonia: rapid presumptive clinical diagnosis with Winthrop-University Hospital's weighted point score system (modified). Cunha BA Heart Lung; 2008; 37(4):311-20. PubMed ID: 18620108 [TBL] [Abstract][Full Text] [Related]
13. A Case of Community-Acquired Pneumonia Due to Legionella pneumophila Serogroup 9 Wherein Initial Treatment with Single-Dose Oral Azithromycin Appeared Useful. Ito A; Ishida T; Tachibana H; Ito Y; Takaiwa T; Fujii H; Hashimoto T; Nakajima H; Amemura-Maekawa J Jpn J Infect Dis; 2017 Nov; 70(6):660-662. PubMed ID: 28890505 [TBL] [Abstract][Full Text] [Related]
14. [Comparative analysis of guidelines for the treatment of community-acquired pneumonias]. Rodríguez de Castro F Arch Bronconeumol; 1999 Jun; 35(6):253-6. PubMed ID: 10410203 [No Abstract] [Full Text] [Related]
15. Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia. Kohno S; Tateda K; Kadota J; Fujita J; Niki Y; Watanabe A; Nagashima M J Infect Chemother; 2014 Mar; 20(3):199-207. PubMed ID: 24477328 [TBL] [Abstract][Full Text] [Related]
16. Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia. Falguera M; Ruiz-González A; Schoenenberger JA; Touzón C; Gázquez I; Galindo C; Porcel JM Thorax; 2010 Feb; 65(2):101-6. PubMed ID: 19703825 [TBL] [Abstract][Full Text] [Related]
17. Atypical pneumonia caused by dual infection with Legionella pneumophila and Mycoplasma pneumoniae. Nunn C; Chereshsky A; Pearce JL N Z Med J; 1990 Oct; 103(900):512-3. PubMed ID: 2122336 [No Abstract] [Full Text] [Related]
18. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy. Bartlett JG Clin Infect Dis; 2008 Dec; 47 Suppl 3():S232-6. PubMed ID: 18986295 [TBL] [Abstract][Full Text] [Related]
19. Severe Pneumonia Caused by Legionella pneumophila: Differential Diagnosis and Therapeutic Considerations. Chahin A; Opal SM Infect Dis Clin North Am; 2017 Mar; 31(1):111-121. PubMed ID: 28159171 [TBL] [Abstract][Full Text] [Related]
20. Validating a clinical prediction score for Legionella-related community acquired pneumonia. Beekman RRAL; Duijkers RR; Snijders DD; van der Eerden MM; Kross MM; Boersma WWG BMC Infect Dis; 2022 May; 22(1):442. PubMed ID: 35534798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]